Article

Plasma GFAP, NfL, and p-tau181 levels as early biomarkers of dementia in Chinese adults: Shenzhen community cohort study

2024-10-30

Abstract excerpt

<title>Abstract</title> Background Although blood-based biomarkers can be used to detect early Alzheimer’s disease (AD), population differences affect their clinical value in early diagnosis of the disease spectrum. Aims To examine the potential of plasma biomarkers to detect different stages along the AD continuum in a Chinese population Methods We enrolled 113 adults from the Shenzhen community (53 cognit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 356b828d-9270-5365-909d-031cf3d5ce88
DOI: 10.21203/rs.3.rs-5282562/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Plasma GFAP, NfL, and p-tau181 levels as early biomarkers of dementia in Chinese adults: Shenzhen community cohort studyDOI 10.21203/rs.3.rs-5282562/v1Read

Plasma Biomarkers in the Distinction of Alzheimer’s Disease and Frontotemporal DementiaSemantic proximity Read

JOINT CONTRIBUTION OF MARKERS OF NEURODEGENERATION AND HYPERCHOLESTEROLEMIA TO DEMENTIA RISKSemantic proximity Read

Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South ChinaSemantic proximity Read

The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementiaSemantic proximity Read

APOEandTREM2variants differentially influence glial fibrillary acidic protein and neurofilament light in plasma of UK Biobank participantsSemantic proximity Read

Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review.Semantic proximity Read

Performance of Plasma Amyloid β, Total Tau and Neurofilament Light Chain Levels for Alzheimer’s Disease IdentificationSemantic proximity Read

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s diseaseSemantic proximity Read

Plasma biomarker trajectories: Impact of AD genetic risk and clinical progressionSemantic proximity Read

Plasma biomarker profiles in autosomal dominant Alzheimer’s diseaseSemantic proximity Read

Multi-Omics Modelling of Plasma pTau181, GFAP, and Metabolic Features Enables Risk Stratification in Prodromal Alzheimer’s DiseaseSemantic proximity Read

Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohortSemantic proximity Read